February 16, 2022
Webinar
Strafford Publications
As part of the Strafford Publications’ webinar series, Finnegan partners Mark Feldstein and David Weingarten will review the FDA's recent guidance on biologics and biosimilars and how it impacts patent strategy. For more information, or to register, please see Strafford’s website.
Webinar
Patent Infringement After Duncan Parking Technologies: Doctrine of Equivalents, Claim Construction
August 18, 2022
Webinar
Prosecution First Blog
The CCPA’s Influence on Obviousness-Type Double Patenting Jurisprudence
August 12, 2022
Due to international data regulations, we’ve recently updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
If you have European patents, you need to know about the Unified Patent Court (UPC).